Anavex Life Sciences names Terrie Kellmeyer president and CEO

AVXL•2026-11-03

Anavex Life Sciences appointed Terrie Kellmeyer president and CEO effective Nov. 1, 2026; she will also join the board.

1. Leadership appointment

Anavex Life Sciences appointed Terrie Kellmeyer president and CEO effective Nov. 1, 2026, and she will also join the board. Kellmeyer previously served as interim CEO and senior vice president of clinical development.

Anavex Life Sciences names Terrie Kellmeyer president and CEO

1. Leadership appointment

Related News

CCH Holdings holds extraordinary general meeting

Pinnacle West Q3 revenue rises, EPS beats expectations

EverQuote, Inc.: Needham raises target price to $35 from $30

Sysco falls after lowering annual sales forecast

Rocket One subsidiary Hoth ends HT-001 Phase 2a trial early after positive interim results